Search In this Thesis
   Search In this Thesis  
العنوان
Assessment of bone changes in beta thalassemia major children through measurement of serum level of a new biochemical marker (tartarte resistant acid phosphatase 5b)/
المؤلف
Aziz, Arwa Nadi.
هيئة الاعداد
باحث / اروي نادي عزيز
مشرف / سميرة زين سيد
مشرف / زمزم حسان محمد
مشرف / دعاء الزعيم محمد
الموضوع
Fetal hemoglobin. Hemoglobinopathy - Treatment. Hemoglobinopathy - Genetic aspects. Cell biology. Systems biology.
تاريخ النشر
2022.
عدد الصفحات
64 p. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
طب الأطفال ، الفترة المحيطة بالولادة وصحة الطفل
تاريخ الإجازة
1/1/2022
مكان الإجازة
جامعة المنيا - كلية الطب - طب الأطفال
الفهرس
Only 14 pages are availabe for public view

from 80

from 80

Abstract

Thalassemia bone illness (TBD) is one of a kind: all perspectives, from bone life structures and bone quality to mineral thickness, might be impacted, with significant horribleness including osteoporosis, breaks, spinal deformations, nerve pressure, and agony.
Many elements might add to TBD, including bone marrow development, expanded bone turnover, endocrine and nutrient lacks, poisonousness from iron over-burden, and iron chelation. In a thalassemic patient, a few of these elements might exist together for quite a while and at various degrees. This makes explanation of the general commitment to TBD and choice of the best restorative choices troubles. The early finding of TBD by TRAP and DEXA is a significant sort of preventive medication. TRAP and DEXA are successful analytic method and has been proposed as a way to understand this point. The fundamental benefits are further developed precision, awareness and explicitness over the accessible existing strategies, and its reasonableness for costeffective The fundamental point of this study was to evaluate bone sickness in TBD among thalassemic youngsters through TRAP appraisal, and to analyze TBD as soon as conceivable to limit dreariness and mortality in thalassemic patients. This forthcoming logical observational review was led 30 beta thalassemic significant youngsters at Minia college from January 2021 to November 2021. The fundamental aftereffects of the review uncovered that:
the fundamental attributes of the considered thalassemic kids as per the age the mean ± SD was 8.2±2.25and the reach was (616).
Concerning loads, the mean ± SD was 8.5 ± 7.8 and the reach was (325). On account of tallness, the mean ± standard deviation was 10.5 ± 13.4, and the reach was (350). For BMI, the mean ± SD was 10.9 ± 12.8 with a scope of (350). Of the 30 cases contemplated, 13 (43.3%) were male and 17 (56.7%) were female.
Thirty youngsters with serious type of beta thalassemia were partitioned into two gatherings.
Bunch 1: 15 for monotherapy
Bunch 2: 15 for double treatment
As indicated by the length of the sickness, the middle worth was 2, the mean ± standard deviation was 2.67 ± 2.22, and the disperse was 0.58. There were 11 splenectomy patients and 19 non-splenectomy patients.
As per Amount of blood bonding each year the middle was 2255(1620 3930) and the mean ± SD was 2767.66 ± 1570.8 and the reach was 1020 - 7300.
As respect Frequency of blood bonding, the middle was 34 (3045)
furthermore the mean ± SD was 39 ± 11 and the reach was 21 - 60.
as indicated by the hemoglobin level, the Mean ± SD was 7.23 ± 0.73 and the middle was 7.2 and the reach was 6 - 8.7.
Worried to add up to leucocytic count, the Mean ± SD was 11.75 ± 5.12 and the middle was 11.2 and the reach was 4.6 - 25.3.
As respect Platelets, the Mean ± SD was 378.43± 127.05 and the middle was 33600 and the reach was 184000 - 625000.
there was altogether expansion in span of sickness in patients on twofold treatment than patients on single treatment (11.6 ± 3.14 versus 6.98 ± 2.2, p0.05). there was fundamentally distinction in TRAP in patients on twofold treatment than patients on single treatment (1.76 ± 1.08 versus 3 ± 2.57, p= 0.038). In the mean time there was no genuinely critical contrasts between the two gatherings in regards to Hb, TLCs, Platelets, MCV, Ca, Ferritin, DEXA. there was critical expansion in measure of blood bonding in patients on twofold treatment than patients on single treatment (3615.3 ± 1773.86 versus 1920 ± 651.8, p=0.007). In the mean time there was no genuinely huge contrasts between the two gatherings with respect to recurrence of blood bonding, span of illness and splenectomy In view of our outcomes we suggest for additional examinations on bigger patients and longer time of follow up to underscore our decision. More public examinations with huge example size are expected to affirm the current outcomes and to decide the related gamble factors. Further investigations on huge geological scale and on bigger example size to stress our decision.